Tributyrin
Tributyrin is an advanced form of butyrate, a short-chain fatty acid (SCFA) naturally produced by beneficial gut bacteria during the fermentation of dietary fiber. Unlike free butyrate, which is rapidly absorbed in the upper gastrointestinal (GI) tract, tributyrin is a glycerol-bound molecule containing three butyric acid units. This unique structure allows tributyrin to deliver butyrate more effectively to the lower GI tract, enhancing its bioavailability and therapeutic potential.
One of the key actions of tributyrin is its ability to modulate the intestinal microbiome. By supporting the growth of beneficial bacteria, tributyrin helps create a balanced microbial environment, suppresses the overgrowth of harmful bacteria, reduces gut inflammation, and promotes overall symbiosis in the digestive system. It also plays a crucial role in promoting the health of colonocytes—the cells that line the colon. Because butyrate is the primary energy source for these cells, tributyrin’s targeted delivery supports cell regeneration, maintains gut lining integrity, and encourages the natural turnover of damaged cells through apoptosis.
Tributyrin also contributes to the regulation of gut permeability by strengthening tight junctions between intestinal epithelial cells. This action helps reduce the phenomenon commonly referred to as "leaky gut," in which toxins, bacteria, and undigested food particles cross into the bloodstream, potentially triggering systemic inflammation and autoimmune responses. Additionally, tributyrin exhibits anti-inflammatory effects by modulating nuclear factor-kappa B (NF-κB) signaling and boosting the production of regulatory T cells (Tregs), both of which help reduce inflammatory cytokine activity and promote immune tolerance.
From an epigenetic standpoint, butyrate acts as a histone deacetylase (HDAC) inhibitor, regulating gene expression in ways that support gut health, immune function, and even anti-cancer mechanisms. These diverse actions give tributyrin a wide range of clinical applications. For gut health, it supports recovery from conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and colitis, while improving symptoms like bloating, irregular bowel movements, and abdominal discomfort.
In terms of immune support, tributyrin enhances the function of gut-associated lymphoid tissue (GALT), which plays a central role in the body’s immune defenses. It helps modulate immune responses to reduce autoimmunity and allergic reactions. Tributyrin also benefits metabolic health by improving glucose regulation and lipid metabolism and may help mitigate inflammation associated with obesity. Through its influence on the gut-brain axis, tributyrin can impact neurotransmitter production and reduce neuroinflammation, offering potential benefits for conditions such as depression, anxiety, and neurodegenerative diseases.
CoreBiome™️ is a novel, patent-pending formulation of tributyrin designed to optimize its delivery and efficacy. Each softgel contains 300 mg of high-purity tributyrin, offering sustained release throughout the digestive tract for maximum therapeutic benefit.
Compared to free butyrate, tributyrin offers several advantages. It is more stable during digestion, ensures effective delivery to the colon, and is far better tolerated—being odorless and free from the gastric irritation often associated with free butyrate. Its slow release and broad systemic effects make it an excellent choice for those seeking support across gut, immune, metabolic, and neurological health.